Abstract
In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis.
1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme.
2
Subject
Pediatrics, Perinatology, and Child Health
Reference21 articles.
1. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage;Lucidarme;J Infect,2015
2. Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003–2005;Ladhani;Pediatr Infect Dis J,2010
3. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity;Campbell;Clin Vaccine Immunol,2010
4. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines;Ladhani;Vaccine,2012
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献